Product
CDX-3379
1 clinical trial
1 indication
Indication
Head and Neck Squamous Cell CarcinomaClinical trial
A Phase 2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of CDX-3379 in Combination With Cetuximab in Patients With Advanced Head and Neck Squamous Cell CarcinomaStatus: Terminated, Estimated PCD: 2020-09-16